Literature DB >> 3852834

Species dependent variability in the susceptibility of coagulase-negative staphylococci to various antimicrobial agents.

K V Rolston, P Thirolf, D S Ho, G P Bodey.   

Abstract

The in-vitro activity of 20 beta-lactam antibiotics and vancomycin was determined against three different species of coagulase-negative-staphylococci. All isolates were susceptible to vancomycin (MIC90 3.12-6.25 mg/l) although occasional tolerance was seen. Most isolates (85%) of Staphylococcus hominis were susceptible to methicillin and other beta-lactams including cephalothin, cefapirin, cefamandole, imipenem and BMY28142, while 90% of Staph. haemolyticus isolates were resistant to these agents. Staph. epidermidis was intermediate in susceptibility with 50% of isolates being methicillin resistant (MR). These MR isolates exhibited cross-resistance or tolerance to the other beta-lactam agents except cefamandole.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3852834     DOI: 10.1093/jac/16.5.659

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  5 in total

1.  Susceptibility of group B and group G streptococci to newer antimicrobial agents.

Authors:  K V Rolston
Journal:  Eur J Clin Microbiol       Date:  1986-10       Impact factor: 3.267

2.  In vitro activity of LY264826, a new glycopeptide antibiotic, against gram-positive bacteria isolated from patients with cancer.

Authors:  K V Rolston; H Nguyen; M Messer
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

3.  Comparative in vitro activity of cefpirome (HR 810) against gram-positive isolates from cancer patients.

Authors:  K V Rolston; G P Bodey
Journal:  Infection       Date:  1986 May-Jun       Impact factor: 3.553

Review 4.  Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  L B Barradell; H M Bryson
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

5.  Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents.

Authors:  Diane M Citron; Ellie J C Goldstein; C Vreni Merriam; Benjamin A Lipsky; Murray A Abramson
Journal:  J Clin Microbiol       Date:  2007-07-03       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.